Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Ng · SciRah

Researcher profile · Semantic Scholar

M. Ng

Share profile

M. Ng — researcher profile on SciRah

h-index: 14
Works: 44
Citations: 897

Most-cited papers

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K. Muro, E. Van Cutsem, Y. Narita, G. Pentheroudakis +24 more
2019Annals of Oncology209 citations Open access
Semantic Scholar
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K. Muro, E. Van Cutsem, Y. Narita, G. Pentheroudakis +24 more
2019Annals of Oncology179 citations Open access
Semantic Scholar
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
D. Tai, K. Loke, A. Gogna, N. Kaya +26 more
2021The Lancet Gastroenterology and Hepatology118 citations
Semantic Scholar
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Sarah B. H. Ng, C. Chua, M. Ng, A. Gan +14 more
2017Scientific Reports55 citations Open access
Semantic Scholar
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
M. Thura, A. Q. Al-Aidaroos, Abhishek Gupta, C. Chee +25 more
2019Nature Communications47 citations Open access
Semantic Scholar
Gastric peritoneal carcinomatosis - a retrospective review
H. Tan, C. Chia, G. Tan, S. Choo +5 more
2017World Journal of Gastrointestinal Oncology35 citations Open access
Semantic Scholar
Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer
C. Chua, I. Tan, Yasuhide Yamada, S. Rha +8 more
2015Cancer Chemotherapy and Pharmacology34 citations Open access
Semantic Scholar
A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678.
W. Tai, K. Loke, A. Gogna, Sze-Huey Tan +16 more
2020Journal of Clinical Oncology33 citations
Semantic Scholar
Metastatic gastric cancer: Does the site of metastasis make a difference?
H. Tan, C. Chia, G. Tan, S. Choo +5 more
2018Asia-Pacific Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept “3G” Trial
W. Yong, S. Rha, I. Tan, S. Choo +17 more
2018Clinical Cancer Research21 citations Open access
Semantic Scholar
HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients.
R. Tan, M. D. Camat, M. Ng, T. Lim +3 more
2018Annals of Oncology19 citations Open access
Semantic Scholar
“3G” Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy
Omer An, Yangyang Song, Xinyu Ke, J. So +12 more
2021Cancer Research16 citations Open access
Semantic Scholar
152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
V. Teneggi, M. Ng, D. Tan, V. Subbiah +13 more
201615 citations
Semantic Scholar
Phase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours.
D. Tan, M. Ng, V. Subbiah, W. Messersmith +15 more
2018Annals of Oncology14 citations Open access
Semantic Scholar
A phase 1B dose escalation study of ETC-159 in combination with pembrolizumab in advanced or metastatic solid tumours.
D. Tan, M. Ng, V. Subbiah, W. Messersmith +13 more
2023Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study—An Asian Tertiary Cancer Center Experience
A. Seet, A. Tan, T. Tan, M. Ng +24 more
2021JCO Precision Oncology10 citations Open access
Semantic Scholar
A phase II open-label, single-centre, non-randomized trial of Y90 transarterial radioembolization in combination with nivolumab in Asian patients with intermediate stage hepatocellular carcinoma: An immunological study of radioembolization in combination with anti-PD1 therapy in HCC.
Esther Chang, D. Tai, S. Koo, M. Ng +13 more
20189 citations
Semantic Scholar
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies
J. Ho, V. Heong, W. Yong, R. Soo +23 more
2022Therapeutic Advances in Medical Oncology8 citations Open access
Semantic Scholar
Safety and efficacy of aflibercept in combination with fluorouracil, leucovorin and irinotecan in the treatment of Asian patients with metastatic colorectal cancer
D. Q. Chong, Maria Manalo, M. Imperial, P. Teo +5 more
2016Asia-Pacific Journal of Clinical Oncology8 citations
Semantic Scholar
Single-cell analysis of immune-microenvironment and immune-tumor interaction in human gastric cancers.
Michele Q. L. Goh, Z. Lim, Vivien Koh, Josephine Lum +11 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Microarray-based tumor molecular profiling to direct choice of cisplatin plus S-1 or oxaliplatin plus S-1 for advanced gastric cancer: A multicentre, prospective, proof-of-concept phase 2 trial.
W. Yong, S. Rha, I. Tan, S. Choo +13 more
20175 citations
Semantic Scholar
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
M. Ng, Sylvia Chen, W. Ong, Akhila Balachander +14 more
2022International Journal of Cancer3 citations
Semantic Scholar
Single cell RNA-seq reveals immunosuppressive gastric stem-like cancer cells as a poor prognostic factor
Hong-Kai Lee, Kok Siong Ang, Marion Chevrier, Michelle Goh +28 more
20203 citations Open access
Semantic Scholar
What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center
J. Lam, S. Choo, D. Tai, I. Tan +10 more
2019Asia-Pacific Journal of Clinical Oncology3 citations
Semantic Scholar
Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA).
D. Catenacci, Haeseong Park, H. Uronis, Yoon-Koo Kang +16 more
2018Annals of Oncology3 citations Open access
Semantic Scholar
A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours
A. Tan, A. Seet, S. Choo, D. Tai +5 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
Circulating tumour DNA (ctDNA) burden quantified through low-pass whole genome sequencing as an early pharmacodynamic biomarker of therapeutic response in patients enrolled on phase 1 trials.
A. Tan, Y. Guo, C. Rahman, T. Tan +16 more
2023JCO Global Oncology1 citations Open access
Semantic Scholar
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
M. Thura, A. Q. Al-Aidaroos, Abhishek Gupta, C. Chee +25 more
2021Nature Communications1 citations Open access
Semantic Scholar
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?
M. Ng, S. Choo
2020Annals of Translational Medicine1 citations Open access
Semantic Scholar
Prognostic and predictive value of circulating tumour DNA (ctDNA) by amplicon-based next generation sequencing (NGS) of advanced pancreatic cancer (APC) in a phase I trial of oxaliplatin capecitabine and irinotecan (OXIRI) triplet chemotherapy.
A. Seet, S. Choo, D. Tai, J. Lam +6 more
2020Journal of Clinical Oncology1 citations
Semantic Scholar
Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)
S. Rutella, S. Church, Jayakumar Vadakekolathu, Stephen Reeder +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Margetuximab (M) + pembrolizumab (P) for treatment of patients (pts) with HER2+ gastroesophageal adenocarcinoma (GEA) post-trastuzumab (T): Survival analysis
D. Catenacci, Haeseong Park, H. Uronis, Yoon-Koo Kang +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)
Haeseong Park, H. Uronis, Y.-K. Kang, M. Ng +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
A phase 2 study of trastuzumab in combination with S-1 and cisplatin in first-line human epidermal growth factor receptor (HER)-2-positive advanced gastric cancer.
S. Choo, C. Chua, Yasuhide Yamada, S. Rha +6 more
20141 citations
Semantic Scholar
421eP Multi-centre experience of tolerability of Zolbetuximab (Zolb) in combination with chemo for advanced gastroesophageal adenocarcinoma (GEA) in Singapore (SGP)
J. J. H. Soon, S. Choo, L.T. Long, W. P. Yong +6 more
2025Annals of Oncology0 citations
Semantic Scholar
A Phase II Trial of Y90-Resin Microspheres Radioembolization Followed by Nivolumab in Advanced Hepatocellular Carcinoma– CA 209-678
D. Tai, K. Loke, A. Gogna, N. Kaya +26 more
2021Social Science Research Network0 citations
Semantic Scholar
“3G” Trial: An RNA Editing Signature for Guiding Gastric Cancer Chemotherapy
Omer An, Yangyang Song, Xinyu Ke, J. So +12 more
2020bioRxiv0 citations Open access
Semantic Scholar
P-68 Safety and tolerability of a novel combination regimen OXIRI and its immunomodulatory effect in Asian pancreatic ductal adenocarcinoma patients
S. Chen, W. Ong, S. Lee, A. Seet +5 more
20200 citations Open access
Semantic Scholar
A phase I open-label, non-randomized study of recombinant super-compound interferon (rSIFN-co) in patients with advanced solid tumours
A. Seet, M. C. F. Macapagal, A. Ahmad, G. Li +7 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
Phase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours.
A. Seet, S. Choo, D. Tai, Y.C.J. Lam +6 more
2018Annals of Oncology0 citations Open access
Semantic Scholar
Oxaliplatin (OX), chronomodulated capecitabine, and UGT1A1 genotype-directed dosing of irinotecan (IR) triplet chemotherapy (OXIRI) in patients (pts) with advanced pancreatic cancer (APC).
A. Seet, Sylvia Chen, Ying-Nan Yu, S. Choo +5 more
20180 citations
Semantic Scholar
HER2 positive rates are enriched amongst colorectal cancer brain metastases: A study amongst 1,920 consecutive patients.
R. Tan, C. Chua, S. Koo, S. Choo +11 more
20180 citations
Semantic Scholar
Abstract A027: A phase I open-label, non-randomized study of recombinant compound interferon (rSIFN-co) in patients with advanced solid tumors
S. Choo, W. Tai, M. Macapagal, A. Ahmad +6 more
20160 citations
Semantic Scholar
Abstract CT320: Longitudinal observational study to simultaneously evaluate multiple blood-based biomarkers to track the emergence of metastasis and drug resistance in colorectal cancer
C. Chua, R. Ten, T. Aung, M. Ang +4 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Choo×28
Invite
S. Choo — researcher profile on SciRah
D. Tai×17
Invite
D. Tai — researcher profile on SciRah
C. Chua×11
Invite
C. Chua — researcher profile on SciRah
I. Tan×10
Invite
I. Tan — researcher profile on SciRah

×9

Invite

W. Yong — researcher profile on SciRah

Invite

A. Seet — researcher profile on SciRah

Invite

P. Tan — researcher profile on SciRah

Invite

C. Tham — researcher profile on SciRah

Invite

S. Koo — researcher profile on SciRah

Invite

K. Lim — researcher profile on SciRah

Invite

J. So — researcher profile on SciRah

Invite

T. Tan — researcher profile on SciRah